BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32249488)

  • 1. Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer.
    Chiang KY; Ho JC; Chong P; Tam TC; Lam DC; Ip MS; Lee YG; Lui MM
    Respirology; 2020 Nov; 25(11):1167-1173. PubMed ID: 32249488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
    Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
    Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary best practice in the management of malignant pleural effusion.
    Koegelenberg CFN; Shaw JA; Irusen EM; Lee YCG
    Ther Adv Respir Dis; 2018; 12():1753466618785098. PubMed ID: 29952251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
    Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
    Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.
    Verma A; Chopra A; Lee YW; Bharwani LD; Asmat AB; Aneez DB; Akbar FA; Lim AY; Chotirmall SH; Abisheganaden J
    Curr Drug Discov Technol; 2016; 13(2):68-76. PubMed ID: 27216707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in pleurodesis for malignant pleural disease.
    Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P
    Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
    Feller-Kopman DJ; Reddy CB; DeCamp MM; Diekemper RL; Gould MK; Henry T; Iyer NP; Lee YCG; Lewis SZ; Maskell NA; Rahman NM; Sterman DH; Wahidi MM; Balekian AA
    Am J Respir Crit Care Med; 2018 Oct; 198(7):839-849. PubMed ID: 30272503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the diagnosis and management of malignant pleural effusions.
    Bashour SI; Mankidy BJ; Lazarus DR
    Respir Med; 2022 May; 196():106802. PubMed ID: 35287006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERS/EACTS statement on the management of malignant pleural effusions.
    Bibby AC; Dorn P; Psallidas I; Porcel JM; Janssen J; Froudarakis M; Subotic D; Astoul P; Licht P; Schmid R; Scherpereel A; Rahman NM; Cardillo G; Maskell NA
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 30054348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
    Fysh ETH; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YCG
    Chest; 2015 Jun; 147(6):1629-1634. PubMed ID: 25474713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
    Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
    Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical and Economic Implications of Different Treatment Pathways for Patients with Rapidly Recurrent Malignant Pleural Effusion.
    Ost DE; Goldblatt C; Jung M; Weiss M; Xu S; Taneja A; Erdal E
    Chest; 2024 Jun; ():. PubMed ID: 38838953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
    Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
    Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventional therapies for malignant pleural effusions: the present and the future.
    Thomas R; Francis R; Davies HE; Lee YC
    Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.
    Chopra A; Judson MA; Doelken P; Maldonado F; Rahman NM; Huggins JT
    Chest; 2020 Feb; 157(2):421-426. PubMed ID: 31472154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
    Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
    Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
    Shafiq M; Ma X; Taghizadeh N; Kharrazi H; Feller-Kopman DJ; Tremblay A; Yarmus LB
    Respiration; 2020; 99(3):257-263. PubMed ID: 32155630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.